Bank of New York Mellon’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $950K | Sell |
|
|||||
|
2023
Q4 | $944K | Buy |
|
|||||
|
2023
Q3 | $838K | Buy |
|
|||||
|
2023
Q2 | $831K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $776K | Sell |
|
|||||
|
2021
Q1 | $823K | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $862K | Sell |
|
|||||
|
2020
Q2 | $2.29M | Sell |
|
|||||
|
2020
Q1 | $2.15M | Sell |
|
|||||
|
2019
Q4 | $5.05M | Buy |
|
|||||
|
2019
Q3 | $3.66M | Sell |
|
|||||
|
2019
Q2 | $4.26M | Buy |
|
|||||
|
2019
Q1 | $5.06M | Sell |
|
|||||
|
2018
Q4 | $4.84M | Buy |
|
|||||
|
2018
Q3 | $3.02M | Buy |
|
|||||
|
2018
Q2 | $2.33M | Buy |
|
|||||
|
2018
Q1 | $1.15M | Buy |
|
|||||
|
2017
Q4 | $620K | Sell |
|
|||||
|
2017
Q3 | $3.44M | Buy |
|
|||||
|
2017
Q2 | $3.37M | Sell |
|
|||||
|
2017
Q1 | $4.04M | Buy |
|
|||||
|
2016
Q4 | $3.59M | Sell |
|
|||||
|
2016
Q3 | $3.83M | Buy |
|
|||||
|
2016
Q2 | $4.82M | Buy |
|
|||||
|
2016
Q1 | $2.51M | Buy |
|
|||||
|
2015
Q4 | $2.61M | Buy |
|
|||||
|
2015
Q3 | $239K | Buy |
|
|||||
|
2015
Q2 | $210K | Sell |
|
|||||
|
2015
Q1 | $1.46M | Buy |
|
|||||
|
2014
Q4 | $1.25M | Buy |
|
|||||
|
2014
Q3 | $1.3M | Hold |
|
|||||
|
2014
Q2 | $1.18M | Hold |
|
|||||
|
2014
Q1 | $936K | Buy |
|